Regeneron

Top 20 employers in global biotech and pharma sectors revealed

Read more

Atopic Dermatitis: A hotspot for innovation and investment opportunities, says GlobalData

Read more

Dupixent (dupilumab) gets DCGI approval to treat moderate-to-severe atopic dermatitis

Read more

WHO recommends use of two antibody drugs against Ebola

Read more

US limits use of Regeneron and Eli Lilly COVID-19 antibody treatments amid Omicron spread

Read more

USFDA approves Inmazeb from Regeneron Pharma to treat Ebola

Read more

US, AstraZeneca sign pact for COVID-19 antibody treatment used to treat Trump

Read more

Regeneron, Sanofi arthritis drug fails COVID-19 study

Read more

Regeneron says COVID-19 antibody cocktail may be available by fall

Read more

Sanofi and Regeneron get EU approval for Dupixent

Read more